Skip to main content
Article
Racial, age, and sex disparities in chronic lymphocytic leukemia (CLL) patients treated with novel therapies.
Journal of Clinical Oncology (2018)
  • Meghan Thompson, Hospital of the University of Pennsylvania
  • Chadi Nabhan, Cardinal Health Specialty Solutions, Dublin, OH;
  • Bruce D. Cheson, Georgetown University
  • John Nathan Allan, NewYork–Presbyterian Hospital
  • Paul M. Barr, University of Rochester Medical Center
  • Alan P. Skarbnik, City of Hope National Medical Center
  • Ryan Jacobs, University of Texas at Austin
  • Chaitra Shankar Ujjani, Georgetown University
  • Richard R. Furman, Cornell University
  • Stephen J. Schuster, Abramson Cancer Center, Philadelphia, PA;
  • Nirav Niranjan Shah, Medical College of Wisconsin
  • John M. Pagel, Swedish Cancer Institute, Seattle, WA;
  • Brian Thomas Hill, Cleveland Clinic
  • Danielle M. Brander, Duke University
  • Mazyar Shadman, University of Washington
  • Clive Zent, University of Rochester Medical Center
  • Nicole Lamanna, Columbia University Medical Center
  • Hande H. Tuncer, Tufts Medical Center
  • Frederick Lansigan, Dartmouth–Hitchcock Medical Center
  • Anthony R. Mato, Memorial Sloan Kettering Cancer Center
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.6577
Citation Information
Meghan Thompson, Chadi Nabhan, Bruce D. Cheson, John Nathan Allan, et al.. "Racial, age, and sex disparities in chronic lymphocytic leukemia (CLL) patients treated with novel therapies." Journal of Clinical Oncology Vol. 36 (2018) p. 6577 - 6577
Available at: http://works.bepress.com/john-pagel/300/